Search Results for: DRUG DEVELOPMENT EXECUTIVE Crown Bioscience
Articles
May 31, 2016
DRUG DEVELOPMENT EXECUTIVE - Crown Bioscience: Enhancing the Drug Development Process May 31, 2016
Jean Pierre Wery, President of Crown Bioscience, discusses the requirement for more accurate research models in oncology research, focusing on PDX models that have the ability to more adequately represent the conditions and mechanisms of immunotherapy in human patients.
August 8, 2017
CrownBio Launches Innovative Inflammatory Disease Models to Advance Preclinical Research August 8, 2017
Crown Bioscience recently announced the launch of preclinical models of inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) to help...
April 19, 2017
Crown Bioscience Launches e-Commerce Platform to Commercialize its Life Science Products April 19, 2017
Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services...
April 19, 2017
Crown Bioscience Launches e-Commerce Platform to Commercialize its Life Science Products April 19, 2017
Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services...
March 15, 2016
Crown Bioscience Acquires PreClinOmics, Expands Cardiovascular & Metabolic Disease Portfolio March 15, 2016
Crown Bioscience, Inc., a wholly owned subsidiary of Crown Bioscience International, a global drug discovery and development solutions company providing...
